Cardurion 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CRD-740 / Cardurion
CARDINAL-HF, NCT05409183: Effectiveness of CRD-740 in Heart Failure

Terminated
2
60
Europe, Canada, US, RoW
CRD-740, Placebo
Cardurion Pharmaceuticals, Inc.
Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Cardiovascular Diseases, Heart Diseases
05/23
07/23

Download Options